Works by Pérol, Maurice
Results: 25
Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1526931
- By:
- Publication type:
- Article
Addressing challenges with Matching-Adjusted Indirect Comparisons to demonstrate the comparative effectiveness of entrectinib in metastatic ROS-1 positive Non-Small Cell Lung Cancer.
- Published in:
- BMC Medical Research Methodology, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12874-025-02500-w
- By:
- Publication type:
- Article
Immunothérapie et hospitalisation à domicile.
- Published in:
- Revue Immunité & Cancer, 2022, v. 6, n. 2, p. 90
- By:
- Publication type:
- Article
Combining EGFR and MET Inhibition With Crizotinib in EGFR-mutated Lung Adenocarcinoma Harboring MET Amplification: A Brief Report.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer Patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Diffuse interstitial lung disease linked to vandetanib.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Are Clinical Guidelines Applied in Routine Daily Practice? A French Regional Survey of Physicians' Clinical Practices in Lung Cancer Management (EPOTRA).
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 5, p. 298, doi. 10.1016/j.cllc.2011.04.003
- By:
- Publication type:
- Article
Systematic Screening for Occupational Exposures in Lung Cancer Patients: A Prospective French Cohort.
- Published in:
- International Journal of Environmental Research & Public Health, 2018, v. 15, n. 1, p. 65, doi. 10.3390/ijerph15010065
- By:
- Publication type:
- Article
Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin--gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-953
- By:
- Publication type:
- Article
Assessment of Treatment Effects and Long-term Benefits in Immune Checkpoint Inhibitor Trials Using the Flexible Parametric Cure Model: A Systematic Review.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 12, p. e2139573, doi. 10.1001/jamanetworkopen.2021.39573
- By:
- Publication type:
- Article
Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay.
- Published in:
- PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0234302
- By:
- Publication type:
- Article
Expérience de suivi à domicile des patients atteints d'un cancer et traités par immunothérapie.
- Published in:
- Bulletin Infirmier du Cancer, 2021, v. 21, n. 2, p. 47, doi. 10.1684/bic.2021.149
- By:
- Publication type:
- Article
Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Healthcare resource utilization in advanced non-small-cell lung cancer: post hoc analysis of the randomized phase 3 REVEL study.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 1, p. 117, doi. 10.1007/s00520-020-05459-0
- By:
- Publication type:
- Article
Exposure-response relationship for ramucirumab from the randomized, double-blind, phase 3 REVEL trial (docetaxel versus docetaxel plus ramucirumab) in second-line treatment of metastatic non-small cell lung cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Bulletin de synthèse de veille 2006.
- Published in:
- Oncologie (Tech Science Press), 2007, v. 9, n. 4, p. 313, doi. 10.1007/s10269-007-0649-6
- By:
- Publication type:
- Article
Corrigendum: High Circulating Sonic Hedgehog Protein Is Associated With Poor Outcome in EGFR-Mutated Advanced NSCLC Treated With Tyrosine Kinase Inhibitors.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
High Circulating Sonic Hedgehog Protein Is Associated With Poor Outcome in EGFR-Mutated Advanced NSCLC Treated With Tyrosine Kinase Inhibitors.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.747692
- By:
- Publication type:
- Article
Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1751, doi. 10.3390/cancers14071751
- By:
- Publication type:
- Article
Implementing ctDNA Analysis in the Clinic: Challenges and Opportunities in Non-Small Cell Lung Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3112, doi. 10.3390/cancers12113112
- By:
- Publication type:
- Article
Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 4, p. 585, doi. 10.1007/s11523-023-00976-4
- By:
- Publication type:
- Article
A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 6, p. 801, doi. 10.1007/s11523-021-00848-9
- By:
- Publication type:
- Article
Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors.
- Published in:
- 2018
- By:
- Publication type:
- journal article